Spain14-5 international multiresistant Streptococcus pneumoniae clone resistant to fluoroquinolones and other families of antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 3, 2003, Pages 715-719

  Pérez Trallero, Emilio ^a,b   Marimón, José M ^a   Gonzalez, Alberto ^a   Iglesias, Luis ^a  

^a HOSPITAL DONOSTIA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Erythromycin resistance; Mechanism of resistance; Rifampicin resistance

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; JOSAMYCIN; LEVOFLOXACIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CHRONIC BRONCHITIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENOTYPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR TYPING; NONHUMAN; POINT MUTATION; PULSED FIELD GEL ELECTROPHORESIS; SPAIN; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; CELL CLONE; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CLONE CELLS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; HUMANS; POINT MUTATION; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 0037340495     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg106     Document Type: Article

References (10)

1. McGee, L., McDougal, L., Zhou, J., Spratt, B. G., Tenover, F. C., George, R. et al. (2001). Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. Journal of Clinical Microbiology 39, 2565-71.
2. Coffey, T. J., Berron, S., Daniels, M., Garcia-Leoni, M. E., Cercenado, E., Bouza, E. et al. (1996). Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiology 142, 2747-57.
3. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA.
4. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
5. 14-5). Microbial Drug Resistance, in press.
6. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. & Wondrack, L. (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy 40, 2562-6.
7. Pan, X. S., Ambler, S., Mehtar, S. & Fisher, L. M. (1996). Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 40, 2321-6.
8. Padayachee, T. & Klugman, K. P. (1999). Molecular basis of rifampin resistance in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 43, 2361-5.
9. McGee, L., Goldsmith, C. E. & Klugman, K. P. (2002). Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones. Journal of Antimicrobial Chemotherapy 49, 173-6.
10. Garcia-Arenzana, J. M., Montes, M. & Perez-Trallero, E. (1994). Are rifampin-resistant Streptococcus pneumoniae strains a consequence of the increase in cases of tuberculosis? Clinical Infectious Diseases 19, 360-1.